Isomorphic Labs has joined the Virtual Biology Initiative (VBI) as a founding member, aiming to accelerate disease understanding and treatment. CEO Demis Hassabis highlighted the initiative's focus on applying AI to medicine and human health. The VBI is intended to serve as an open resource for researchers worldwide. AI
IMPACT This partnership aims to accelerate AI applications in medicine and disease treatment by creating an open resource for researchers.
RANK_REASON Partnership announcement for a company focused on AI in medicine.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →